Who's running the show?
Ryan P. Hamer (BSc, MBA)
Managing Director
Ryan holds a Bachelor of Science from Swinburne University (Melbourne), a postgraduate degree in Management from Griffith University (Brisbane), and has undertaken specialist training in the U.S and the U.K. Ryan’s clinical and research interests focus on complex cortico-subcortical mapping for neuroplasticity in glioma patients, having previously introduced contemporary brain mapping techniques throughout Australia and Singapore. For Ryan, Neuroclast is a vehicle representative of his life's pursuit in applied clinical neuroscience, one that will foster a PhD and the sharing of knowledge and education in science, electrophysiology, and medical devices. Learn more about Neuroclast's research.
Ryan is a clinical neuroscientist, healthcare executive and medical device enthusiast based in Melbourne, Australia. Having been involved in clinical neurophysiology for over a decade, he has individually served as Clinical Director and Business Development Manager for two multinational clinical neuroscience and healthcare companies, and has been an invited speaker at medical conferences and meetings around Australia, Asia and South Africa. Ryan is also a Clinical Lecturer with the Faculty of Health and Medicine at the University of Sydney, and Unit Coordinator for intraoperative neurophysiology units as part of the Master of Medicine program. In addition to these roles, Ryan is also an Honorary Fellow and PhD Candidate (Dept. of Neurosurgery, St Vincent's Hospital) with the University of Melbourne, and elected as President of the Intraoperative Neurophysiology Society of Asia-Pacific (INSA) for 2020-2024.
Selected works:
-
Hamer RP, Poonnoose S. Arcuate fasciculus cortico-cortical evoked potentials and direct cortico-subcortical stimulation during awake craniotomy for debulking of left dominant temporal oligodendroglioma. Neurosurg Focus Video. 2025;12(1):V5.
-
Hamer RP, Praeger AJ. Facilitating complete resection of intrinsic motor cortex glioma with titration of high-frequency cortico-subcortical mapping train count informed by navigated transcranial magnetic stimulation: illustrative case. J Neurosurg Case Lessons. 2024;8(2).
-
Hamer RP, Chen A, Gogos A. Bilateral epidural D-wave monitoring during resection of an eccentric cervical astrocytoma with evidence of asymmetrical corticospinal desynchronization. British Journal of Neurosurgery, 31, 1-7.
-
Hamer R. P. & Yeo T. T. (2022). Current status of neuromodulation-induced cortical prehabilitation and considerations for treatment pathways in lower-grade glioma surgery. Life, 12(4), 466:491.
-
Hamer R. P. et al. (2020). Optimizing the onco-functional balance in supratentorial brain tumour surgery: a single institution's initial experience in cortico-subcortical mapping and monitoring in Singapore. Journal of Clinical Neuroscience, 79, 224-230.
I’ve spent a considerable amount of my career observing neurosurgeons treat brain cancer patients. That’s why Neuroclast exists; to provide functional information to surgeons who help ensure that these patients maintain a good quality of life. At the moment we have a niche product portfolio and data infrastructure that will permit clinicians and hospitals to optimise patient outcomes and publish their own results with ease. Nexstim in particular represents a tremendous opportunity for me as a scientist, not only to introduce new neuro-imaging techniques in the ANZ region, but also to contribute to our over-arching pursuit to help preserve life with onco-functional insight, and contribute to the new era of functional localisation of the brain.
In the field:
Sean Carroll BSc
A/Product Manager (Functional Neurosurgery)
& Clinical Applications Consultant
Joining the team in July 2024, Sean brings a diverse wealth of project management and leadership experience partnered with his academic foundations in clinical neuroscience. Actively engaged in pre-surgical and intraoperative brain mapping, Sean has also recently assisted in the Australian launch of the SUSy stereotactic system, and shows great interest and
enthusiasm toward clinical electrophysiology, neuro-oncology surgery and academia.
"It has been a privilege to be involved with the work being undertaken by Neuroclast and to adopt the overall mission of the company. The insight I have been afforded from patients ahead of their surgeries has at times stirred a wide range of emotions, but left me admiring the reliance of these people and their families. Being involved in nTMS from the get-go has provided a substantial anchor to maintain a mindfulness regarding the lives of each person who enters the OR, the often sudden and recent events that have brought them to surgical intervention, and why they are choosing to be there."
Hannah Ginman Makin BSc Hons
Clinical Applications Consultant
Following completion of a Bachelors (Honours) degree in Neuroscience at the University of Leeds in 2023, Hannah relocated from the UK to Melbourne in February 2025 to pursue a career in clinical electrophysiology within neuro-oncology surgery. Hannah’s academic background and internal accreditation has supported the development of both preoperative and intraoperat-
ive expertise in brain mapping. Hannah is also involved in navigated transcranial magnetic stimulation (nTMS) sessions with patients prior to surgery and contributes to intraoperative decision-making through motor and language mapping in both awake and asleep procedures, including arcuate fasciculus CCEP and ACEP monitoring. Alongside her clinical work, Hannah has a strong interest in research and aims to contribute to Neuroclast's academic pipieline as a Research Assistant.
"Amongst the excitement of learning and
adopting new skills, there is a heavy emotional side to this job. As the months have progressed, I connect more with patients when I talk to them. I can see the fear in their eyes, but every single one of them has been so brave. They deserve for me to know my craft inside and out, because if it was my relative on the table I sure as hell would want everyone in the room to be on it."
Jackie Farragher MSc, BSc (Chemistry), BSc (Psychophys)
Clinical Education
& Applications Consultant
Jackie brings over a decade of experience across diagnostic and intraoperative neurophysiology, neuromodulation, and medical device sales. Holding dual Bachelor of Science degrees in Psychophysiology and Chemistry from Swinburne University of Technology, alongside a Master of Science from Western Sydney University, Jackie has built her expertise across some of Australia's most demanding clinical and surgical environments.
Her career has taken her from the operating theatre to the bedside and everywhere in between; performing multimodal IONM during complex neurosurgical procedures, delivering clinical support for deep brain stimulation implantation, and conducting routine EEGs across emergency, ICU, and outpatient settings. Along the way, Jackie gained support and sales experience at a multinational medical device distributor as both a Clinical Support Specialist and Associate Territory Manager, working across implant systems and surgical navigation platforms for complex spinal and neurosurgical procedures.
What sets Jackie apart is the rare combination of scientific rigour and clinical adaptability she brings to every environment she works in. Years of direct collaboration with surgeons, anaesthetists, and multidisciplinary teams has made her a competent and capable collaborator and clinical educator.
“In neurophysiology, we often meet patients on what can be one of the most challenging days of their lives. I see my role as doing everything I can to bring a sense of calm, precision, and reassurance in that moment. It’s a privilege to be trusted in that space, and I’m proud to be part of a team at Neuroclast that shares such a strong commitment to patient care, clinical excellence, and continual learning”.
Why are we here?
Our goal is to facilitate access to technologies that might reduce the impact of debilitating neurologic injury. A lot of the time these technologies are related to mapping the human brain, though this also involves technology relating to virtual reality and electrophysiology.
First and foremost, we invest in our employees. We're committed to building an environment that fosters professional growth in order to meet the needs of clinicians and patients.
We invest in the technology of our business partners, and generate revenue for new business partners, to introduce various medical technologies to ANZ.
We will also distribute a portion of revenue towards novel research and development relating to neuroscience, neurosurgery and electrophysiology. This will also involve co-sponsorship of research funding with academic and medical institutions.
As a company, we are dedicated to finding ways to assist clinicians in their plight against brain cancer and neurodegenerative disease, and meaningfully contributing to clinical education and research. More often than not, this means partnering with world-class medical device companies around the world to introduce their technology in ANZ.
We look to employ people that are independently minded and lateral thinkers that are solutions-oriented. We are also hell-bent on the fostering and development of graduate professionals entering the healthcare and medtech industry.
We're also big on transparency. We're a small but growing business, and it's important we include our prospective customers with how we're distributing revenue from your interest in our products and services.
The company also expects to align with various charities and fundraising efforts for these charities to increase awareness of causes and centres related to neurodegenerative disease.
Iconoclast
icon·o·clast | ʌɪˈkɒnəklast
A person who challenges settled beliefs or institutions. If you describe someone as an iconoclast, you mean that they often question dogmatic beliefs and standards that are generally accepted by society, in order to benefit society.
Neuro
neu·ro | nu̇r-ō
Of or relating to the human nervous system.
